Challenges in Hematopathology
April 3 - 5, 2020
Physicians Can Earn A Maximum Of 12 AMA PRA Category 1 Credits™
Physicians Can Earn A Maximum Of 12 SAM Credit Hours
USCAP Member $999, Non-Member $1,349, Pathologist-in-Training $799
Daniel A. Arber, MD
University of Chicago
Dr. Arber attended Texas A&M University and the University of Texas Health Science Center Medical School in San Antonio, Texas. After a rotating internship in Monroe, Louisiana, he did a residency in Anatomic and Clinical Pathology at the Scott & White Clinic in Temple, Texas. He was then a fellow in Hematopathology at City of Hope National Medical Center in Duarte, California with training from Henry Rappaport, Lawrence Weiss, Hector Battifora, Russell Brynes and others. Dr. Arber was the Director of Hematopathology and Molecular Pathology at City of Hope prior to moving to Stanford University. At Stanford, he was the Ronald F. Dorfman Professor of Hematopathology and Vice Chair of Clinical Services. In 2016, he moved to the University of Chicago where he is the Donald West and Mary Elizabeth King Professor and Chair of Pathology.
Dr. Arber’s research interest is in the diagnosis, classification and molecular genetic changes of hematologic and splenic neoplasms. He is a co-editor/author of nine textbooks, including two editions of Hematopathology and three editions of Wintrobe’s Clinical Hematology. His publications include over 300 original articles and book chapters in the area of hematopathology and diagnostics. He was a senior advisor for the 2016 WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. He is a past member of the Board of Directors of the United States and Canadian Academy of Pathology and a past President of the Society for Hematopathology.
M. Kathryn Foucar, MD
University of New Mexico
Dr. Foucar is a graduate of the Ohio State University School of Medicine, and she completed her pathology residency at the University of New Mexico/University of Minnesota, followed by a surgical pathology fellowship at the University of Minnesota. During her 35 years as a diagnostic hematopathologist at the University of New Mexico Health Sciences Center, Dr. Foucar has served in a variety of educational and leadership roles. She is the former Director of the Hematopathology Fellowship Training Program and a co-founder of this program. She is also the former Director of the Division of Hematopathology and a former Vice Chair of Clinical Affairs. Dr. Foucar has served as President of the Society for Hematopathology and is a past board member of the American Society of Clinical Pathology. She has also served on various educational committees for ASCP, USCAP and the Society for Hematopathology.
Dr. Foucar has served on the faculty for the Tutorial for Neoplastic Hematopathology for over 25 years. Her career focus is on diagnostic hematopathology and she has authored, co-authored, or served as editor for multiple hematopathology texts and text atlases including AFIP Fascicles on Tumours of the Bone Marrow and Non-Neoplastic Disorders of the Bone Marrow, and Bone Marrow Pathology, Fourth Edition (in press).
Rebecca L. King, MD
Dr. King is an Associate Professor in the Division of Hematopathology at Mayo Clinic in Rochester, Minnesota. She is the hematopathology fellowship director, and co-director of the Mayo Clinic multidisciplinary lymphoma E-tumor board. Dr. King completed medical school and AP/CP residency at the University of Pennsylvania in Philadelphia, PA. She completed hematopathology fellowship at Mayo Clinic and then joined the faculty at the Children’s Hospital of Philadelphia before being recruited back to Mayo in 2014 for a clinical focus on lymphoma pathology. She served as the head of the Division’s Lymphoma Working Group for two years.
Dr. King’s clinical service includes predominantly diagnostic lymphoma pathology, as well as bone marrow, flow cytometry, and molecular hematopathology. She is actively involved in educational activities with USCAP as well as the Society for Hematopathology and European Association for Hematopathology. She has authored numerous manuscripts and book chapters on practical aspects of lymphoma diagnosis and the utility of genetic testing in routine hematopathology practice. Through Mayo’s consultative practice, she has a unique lens into the challenges facing practicing pathologists in various diagnostic settings and seeks to highlight these challenges in her courses and lectures.
Girish Venkataraman, MD, MBBS
University of Chicago
Dr. Venkataraman is associate professor in Hematopathology and medical director of the Clinical Immunohistochemistry Laboratory at University of Chicago Medical Center, Chicago, IL.
He obtained his medical degree at Kilpauk Medical College, Chennai, India (1997), and received his MD from Loyola University Medical Center (2004-2008). He then obtained his clinical hematopathology fellowship training at the National Cancer Institute (2008-2010) after which he assumed a faculty position at Loyola University Medical Center (2010-2013) before moving on to University of Chicago where he works presently. He is currently the Editor-in-Chief of the American Society of Hematology Image Bank, vice-president of the Chicago Pathology society, and is currently also an active member of the CAP Quality Practices Committee and also participated/directed CME activities for CAP, ASCP and Ultmann Chicago Lymphoma symposium as well as the LRF. His research interests focus on the borderlands of Hodgkin lymphoma with other lymphoma entities.